Last reviewed · How we verify
NCT04476771
Cultivating Well-being in Subclinical Paranoia
NA trial testing Feliz-Mente (third generation psychotherapy) in Wellbeing in 50 participants. Completed in 25 September 2019.
25 September 2019
Quick facts
| Lead sponsor | Universidad Complutense de Madrid |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 10 October 2017 |
| Primary completion | 25 September 2019 |
| Estimated completion | 25 September 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Feliz-Mente (third generation psychotherapy)
Conditions studied
- Wellbeing — all drugs for Wellbeing →
Sponsor
Universidad Complutense de Madrid — full company profile →
Who can join
Adults 18 to 35, any sex, with Wellbeing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and aims to build a more meaningful self-narrative in persons with subclinical paranoia. Feliz-Mente is a group intervention of 12 sessions in which participants are expected to perform exercises during and between sessions by the use of a mobile application to improve treatment adherence and daily practice. The design for the present study is a randomized controlled trial, which compares the post-intervention measures of the experimental group (group receiving the intervention and the daily use of a mobile application of the program) with the post-intervention measures of the control group (treatment as usual + waiting list).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Temporal Network Approach to Paranoia: A Pilot Study.
Contreras A, Valiente C, Heeren A, Bentall R. · · 2020 · cited 20× · PMID 33041912 · DOI 10.3389/fpsyg.2020.544565
Verify or expand the search:
- PubMed search for NCT04476771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wellbeing
Currently open trials in the same condition.
- NCT07494110 — Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations · NA · recruiting
- NCT07480018 — Berberine Supplementation, Sprint Interval Training, and Immune Function Study · NA · recruiting
- NCT07361159 — Health and Wellness Coaching to Improve Thoracic Transplant Caregiver Self-Efficacy · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06871397 — Effectiveness of an Online Biopsychosocial Intervention to Improve Well-being and Mental Health During Pregnancy · NA · recruiting
Other Universidad Complutense de Madrid trials
Trials by the same sponsor.
- NCT07361848 — Long-Hold Yielding Isometric Exercise for Patellar Tendinopathy in Weightlifting Athletes · NA · not yet recruiting
- NCT07273006 — Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation · Phase 4 · not yet recruiting
- NCT07527351 — ANALYSIS OF THE RELIABILITY AND VALIDITY OF LASER SPECKLE CONTRAST IMAGING · NA · recruiting
- NCT07484620 — Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease · NA · not yet recruiting
- NCT07485400 — Aerobic Interval vs Continuous Training on Heart Rate-Power Decoupling in Ischemic Heart Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04476771 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Complutense de Madrid
- Last refreshed: 20 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04476771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing